Moyamoya disease (Moyamoya disease) is a disease in which the terminal part of arterial blood vessels in the brain that ...

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive ...

The Phase I trial of the company’s SRSD107 siRNA therapy found the treatment to be safe and well tolerated as part of its ...

In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the ...

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

Children who received a stem cell transplant for sickle cell disease (SCD) experienced better quality of life outcomes and cognitive perfo ...

In response to this global need for more universal and broadly deliverable, frontline treatments, Algernon Pharmaceuticals ...

However, high cost of neurovascular devices and dearth of qualified neurosurgeons required to handle these devices restrict growth of the market. Conversely, high growth rate exhibited by developing ...

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally ...

Johnson & Johnson has rewarded shareholders with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

Medical care given to a patient suffering from liver diseases is termed as liver disease treatment. Furthermore, the treatment includes use of various drugs for different types of liver conditions.